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Objective: During coronary artery revascularization, some surgeons favor
intermittent crossclamping with ventricular fibrillation in preference to car-
dioplegic ischemic arrest for myocardial protection. It is unclear, however,
whether intermittent crossclamping with fibrillation is equally protective or
whether ischemic injury is reduced as a consequence of shorter cumulative
ischemia.
Methods: We used isolated, Langendorff-perfused rat hearts, measured preis-
chemic function (left ventricular developed pressure) with an intraventricu-
lar balloon, and then subjected the hearts to either (1) 40 minutes of global
ischemia, (2) a 2-minute infusion of cardioplegic solution and 40 minutes of
ischemia, (3) multidose (every 10 minutes) infusions of cardioplegic solution
during 40 minutes of ischemia, (4) continuous ventricular fibrillation during
40 minutes of ischemia, (5) intermittent (4 × 10 minutes) ischemia with 10
minutes of reperfusion, (6) intermittent (4 × 10 minutes) ischemia preceded
by intermittent cardioplegia, (7) intermittent (4 × 10 minutes) ischemia with
ventricular fibrillation, (8) continuous (40 minutes) ventricular fibrillation
during coronary perfusion, or (9) intermittent (4 × 10 minutes) ventricular
fibrillation (with perfusion). All protocols were followed by 60 minutes of
reperfusion.
Results: After 60 minutes of reperfusion, the percentage recovery of left ven-
tricular developed pressure for groups 1 through 9 was as follows: 32% ±
2%, 57% ± 6%, 82% ± 3%, 19% ± 3%, 73% ± 3%, 70% ± 3%, 78% ± 4%,
55% ± 2%, and 57% ± 3%, respectively. No significant differences were
identified among groups 3, 5, and 7, but the percentage recovery of devel-
oped pressure in group 3 was significantly higher than that in group 6; the
degree of recovery in groups 3 and 5 to 7 was significantly (P < .05) higher
than in groups 1, 2, 4, 8, and 9. Early recovery was significantly (P < .05)
more rapid in groups 3 and 5 to 9, reaching a plateau (of 55%-80%) by 10
minutes of reperfusion; in groups 1, 2, and 4, the recovery plateau occurred
after 50 minutes. Left ventricular end-diastolic pressure was elevated in
groups 1, 2, and 4 but was almost unchanged from baseline in the other
groups.
Conclusions: A similar level of myocardial protection was achieved with
multidose (intermittent) cardioplegia or intermittent crossclamping (with or
without fibrillation), indicating that intrinsic preservation by intermittent
crossclamping with fibrillation does not exacerbate ischemic injury. 
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D uring cardiac surgery, cardioplegic ischemic arrestis the preferred method for myocardial protec-
tion.1,2 However, for isolated myocardial revasculariza-
tion (coronary artery bypass surgery), the technique of
intermittent ventricular fibrillation (VF), either with
continued coronary perfusion3 or, more commonly,
with aortic crossclamping,1,4 has been favored by a
minority of surgeons.
Recently, the use of intermittent crossclamping with
VF for myocardial protection has been re-evaluated
because of its simplicity and because of interest in a
potential connection between intermittent crossclamp-
ing with VF and myocardial protection induced by
ischemic preconditioning. Randomized clinical trials
have shown that myocardial preservation by means of
intermittent crossclamping with VF is equal to or bet-
ter than that obtained with cold cardioplegia,5-11
assessed by clinical outcome,5,8,11 cardiac specific
markers of injury (such as creatine kinase MB isoform
or troponin T assays),6,7,11 free radical activity (such as
lipid peroxidation and plasma antioxidant status),9 and
from preoperative and postoperative electrocardio-
graphic changes.6,9,11 Invariably, the cumulative
ischemic period for intermittent crossclamping with VF
during coronary surgery was relatively short (30-40
minutes) and was generally significantly shorter than
the ischemic period when cardioplegic protection was
used.5,7-11 Thus, from these clinical studies, it remains
unclear whether intermittent crossclamping with VF is
associated with an intrinsic myocardial protective
effect or whether the shorter ischemic duration results
in less severe myocardial injury.
We therefore conducted an experimental study to
investigate whether intermittent crossclamping with
VF has intrinsic myocardial protection and to compare
any protective effect of this technique with those of
other methods of elective cardiac arrest used during
cardiac surgery procedures.
Material and methods
Animals. Adult male Wistar rats (240-300 g body weight)
were used (Bantin and Kingman, Hull, United Kingdom). All
animals received humane care in accordance with the
“Guidance on the Operation of the Animals (Scientific
Procedure) Act of 1986” published by Her Majesty’s
Stationery Office, London, United Kingdom. Rats were anes-
thetized with 95% oxygen and 5% carbon dioxide bubbled
through diethyl ether; they were then anticoagulated with
heparin (1000 IU/kg body weight) administered intravenously.
Heart isolation and perfusion. Hearts were rapidly
excised from the anesthetized rat and immersed in cold (4°C)
Krebs-Henseleit buffer. The aorta was then cannulated and
the heart perfused in the Langendorff mode with Krebs-
Henseleit buffer at a constant pressure (75 mm Hg) and tem-
perature (37°C) within 30 seconds of excision. The pul-
monary artery was incised to allow free drainage of coronary
effluent.
An ultrathin intraventricular balloon, constructed from
cling film (Saran Wrap; S. C. Johnson, Racine, Wis) over a
20-gauge cannula and made to match the internal dimen-
sions of the left ventricle, was then introduced through the
mitral valve into the left ventricle. The balloon, attached to
a pressure transducer that in turn was connected to a chart
recorder system (Gould Instruments, Oxnard, Calif), was
gradually inflated with water to give a stable left ventricu-
lar end-diastolic pressure (LVEDP) of 3.0 to 8.0 mm Hg.
This isovolumic state was maintained throughout the pro-
tocol.
All hearts were subjected to an equilibration period of aer-
obic perfusion for 20 minutes, and baseline readings of left
ventricular systolic pressure (millimeters of mercury),
LVEDP (millimeters of mercury), heart rate (beats per
minute), and coronary flow rate (milliliters per minute) were
then taken. Left ventricular developed pressure (LVDP) was
calculated as the left ventricular systolic pressure minus
LVEDP. Coronary flow rate was measured by timed collec-
tions of the coronary effluent. The development of contrac-
ture during ischemia was recorded by means of the intraven-
tricular balloon.
Exclusion criteria. Hearts not satisfying preassigned
exclusion criteria at the time of the baseline readings (after 20
minutes of aerobic perfusion) were excluded from the study.
The acceptable ranges for LVDP, heart rate, and coronary
flow rate were more than 100 mm Hg, 220 beats/min, and 8
to 16 mL/min, respectively.
Perfusion medium. The perfusion medium was a modified
Krebs-Henseleit bicarbonate buffer with the following com-
position (in millimoles per liter): NaCl, 118.5; NaHCO3,
25.0; KCl, 4.8; MgSO4, 1.2; CaCl2, 1.4; and glucose, 11.0.
The buffer was prepared daily, filtered through a 5-µm pore-
size cellulose nitrate membrane filter before use, and contin-
uously gassed with a mixture of 95% oxygen and 5% carbon
dioxide to give a pH of 7.4 at 37°C.
Preparation and administration of cardioplegic solu-
tion. In studies involving cardioplegia, the St Thomas’
Hospital cardioplegic solution No. 2 (STH2), with the fol-
lowing composition (in millimoles per liter), was used: NaCl,
110.0; MgCl2 · 6 H2O, 16.0; KCl, 16.0; CaCl2 · 2 H2O, 1.2;
and NaHCO3, 10.0. STH2 was prepared daily; pH was adjust-
ed to 7.8 at 37°C and then filtered through a 5-µm filter
before use. The solution was delivered at 37°C and at a pres-
sure of 45 mm Hg for 2 minutes every infusion.
Induction and termination of VF. VF was induced by an
electrical fibrillator (model G570, Department of
Bioengineering, St Thomas’ Hospital) by passing alternating
current through two electrodes. The silver electrodes were
coated with silicone; one was attached to the apex of the ven-
tricle and the other to the aortic cannula for grounding. The
minimum voltage necessary to achieve an alternating current
that maintained VF was used.
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If VF occurred during reperfusion or did not terminate
spontaneously after the fibrillator was turned off, it was ter-
minated by the use of a defibrillator (model G434,
Department of Bioengineering, St Thomas’ Hospital).
Experimental design. The perfusion protocols are shown
in Fig 1. After equilibration, hearts were randomly assigned
to 1 of 9 groups. All hearts (n = at least 6 per group) were sub-
jected to one of the following protocols: (1) continuous glob-
al ischemia for 40 minutes (C-GI; n = 9); (2) a single-dose
infusion of STH2 before 40 minutes of continuous global
ischemia (S-CP; n = 9); (3) multidose infusion of STH2
(before and every 10 minutes) throughout 40 minutes of con-
tinuous global ischemia (M-CP; n = 6); (4) 40 minutes of
continuous global ischemia with electrically induced VF
throughout (C-GI+VF; n = 6); (5) 4 intermittent episodes of
10 minutes of global ischemia and 10 minutes of reperfusion
(I-GI; n = 6); (6) 4 intermittent episodes of 10 minutes of
global ischemia preceded by 2-minute infusions of STH2 and
followed by 8 minutes of reperfusion (I-CP; n = 6); (7) 4
intermittent episodes of 10 minutes of global ischemia with
electrically induced VF followed by 10 minutes of reperfu-
sion in sinus rhythm (I-GI+VF; n = 6); (8) continuous elec-
trically induced VF for 40 minutes with coronary perfusion
(C-VF; n = 6); and (9) 4 intermittent episodes of 10 minutes
of electrically induced VF with coronary perfusion followed
by 10 minutes of coronary perfusion in sinus rhythm (I-VF; 
n = 6). LVEDP (intracavity pressure) was measured through-
out these protocols.
All protocols were followed by a further 60 minutes of
reperfusion, when recovery of myocardial function (LVDP,
LVEDP, coronary flow rate, and heart rate) was measured.
Expression of results. Postischemic recovery of LVDP
was expressed as a percentage of baseline values at the end of
20 minutes of aerobic perfusion; LVEDP was expressed as
absolute values (millimeters of mercury). The following mea-
surements related to contracture during ischemia were also
noted: (1) time to onset of contracture (minutes), (2) time to
peak contracture (minutes), and (3) magnitude of peak con-
tracture (millimeters of mercury).
Statistics. Statistical analysis was performed with
StatView and SuperANOVA software (Abacus Concepts, Inc,
Berkeley, Calif) on an Apple Macintosh computer (Apple
Computer, Cupertino, Calif).
All data are reported as mean ± SEM. Comparisons
between groups were assessed for significance by 1-way
analysis of variance with post hoc analysis by means of the
Fisher test, which allowed for multiple comparisons. A value
of P < .05 (probability of < 5% that a difference between
groups occurred by chance) was considered statistically sig-
nificant.
Results
Measurement of baseline values of cardiac func-
tion. The mean baseline values for LVDP, coronary
flow rate, heart rate, and LVEDP at the end of 20 min-
utes of aerobic perfusion are shown in Table I; there
were no significant differences in any of these values
between groups.
Recovery of LVDP. Chronologic changes in postis-
chemic recovery of LVDP are shown in Fig 2. Very dif-
ferent recovery responses were obtained; in groups 3
and 5 to 9, hearts recovered rapidly, reaching a plateau
by 10 minutes of reperfusion (at this time point, these
values were significantly higher than those of groups 1,
2, and 4). In contrast, groups 1, 2, and 4 recovered
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Fig l. Experimental perfusion protocols. Nine groups of
hearts (n = at least 6 per group) were studied: group 1: 40
minutes of continuous global ischemia (C-GI; n = 9); group
2: a single-dose infusion of St Thomas’ Hospital solution 2
(STH2) and 40 minutes of global ischemia (S-CP; n = 9);
group 3: multidose infusions of STH2 (every 10 minutes)
throughout 40 minutes of global ischemia (M-CP; n = 6);
group 4: continuous VF throughout 40 minutes of global
ischemia (C-GI+VF; n = 6); group 5: 4 × 10 minutes of glob-
al ischemia (with 10 minutes of reperfusion) (I-GI; n = 6);
group 6: 4 × 10 minutes of global ischemia with intermittent
STH2 (with 10 minutes of reperfusion) (I-CP; n = 6); group
7: 4 × 10 minutes of global ischemia with intermittent VF
(and 10 minutes of reperfusion) (I-GI+VF; n = 6); group 8:
40 minutes of continuous VF with coronary perfusion (C-VF;
n = 6); group 9: 4 × 10 minutes of VF with coronary perfu-
sion (I-VF; n = 6). All protocols were followed by 60 minutes
of reperfusion.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 120, Number 3
Bessho and Chambers 531
slowly and did not reach a plateau until 50 to 60 min-
utes of reperfusion. Recovery was poorest in hearts
subjected to continuous (40 minutes) global ischemia
(group 1) or continuous (40 minutes) global ischemia
with VF (group 4); surprisingly, however, hearts pro-
tected with a single infusion of STH2 before 40 min-
utes of continuous ischemia (group 2) also recovered
relatively slowly.
The final recovery of LVDP after 60 minutes of
reperfusion in all groups is shown in Fig 3. The highest
Fig 2.  Recovery of LVDP with reperfusion duration (minutes), expressed as a percentage of the preischemic control
value. *P < .01: groups 3, 5, 6, 7, 8, and 9 versus groups 1, 2, and 4. Values are the mean of at least 6 hearts per group;
error bars have been removed to improve clarity. LVDP, Left ventricular developed pressure; C-GI, continuous global
ischemia group; S-CP, single-dose cardioplegic infusion group; M-CP, multidose cardioplegic infusion group; C-
GI+VF, continuous global ischemia with ventricular fibrillation group; I-GI, intermittent global ischemia group; I-CP,
intermittent cardioplegic infusion group; I-GI+VF, intermittent global ischemia with ventricular fibrillation group; C-
VF, continuous ventricular fibrillation group; I-VF, intermittent ventricular fibrillation group.
Fig 3. Recovery of LVDP at the end of 60 minutes of reperfusion, expressed as percentage of the preischemic con-
trol value. Values are the mean of at least 6 hearts per group ± SEM. *P < .05 vs groups 1, 2, 4, 8, and 9. LVDP,
Left ventricular developed pressure; C-GI, continuous global ischemia group; S-CP, single-dose cardioplegic infu-
sion group; M-CP, multidose cardioplegic infusion group; C-GI+VF, continuous global ischemia with ventricular
fibrillation group; I-GI, intermittent global ischemia group; I-CP, intermittent cardioplegic infusion group; I-
GI+VF, intermittent global ischemia with ventricular fibrillation group; C-VF, continuous ventricular fibrillation
group; I-VF, intermittent ventricular fibrillation group.
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Table II.  Results of post hoc analysis for recovery of LVDP after 60 minutes of reperfusion
P values
Group 1 Group 2 Group 3 Group 4
Group 1: C-GI — <.0001 <.0001 .0288 
Group 2: S-CP <.0001 — <.0001 <.0001 
Group 3: M-CP <.0001 <.0001 — <.0001 
Group 4: C-GI+VF .0288 <.0001 <.0001 —
Group 5: I-GI <.0001 .0074 .0934 <.0001
Group 6: I-CP <.0001 .0271 .034 <.0001
Group 7: I-GI+VF <.0001 .0004 .4197 <.0001
Group 8: C-VF .0009 .6719 <.0001 <.0001
Group 9: I-VF .0005 .9188 <.0001 <.0001
Table III.  Characteristics of ischemic contracture (time to onset, time to peak, and peak contracture) in those 
groups in which a complete contracture occurred
Groups
1: C-GI 2: S-CP 3: M-CP 4: C-GI+VF 
Time to onset (min) 15.3 ± 1.1 26.8 ± 0.8* — 11.4 ± 0.3†
Time to peak (min) 19.1 ± 1.2 30.5 ± 0.9* — 14.0 ± 0.2‡
Peak (mm Hg) 67.7 ± 5.9 50.0 ± 2.9* — 95.2 ± 5.8†
P value, Probability value; LVDP, left ventricular developed pressure; C-GI, continuous global ischemia group; S-CP, single-dose cardioplegic infusion group; M-CP,
multidose cardioplegic infusion group; C-GI+VF, continuous global ischemia with ventricular fibrillation group; I-GI, intermittent global ischemia group; I-CP, inter-
mittent cardioplegic infusion group; I-GI+VF, intermittent global ischemia with ventricular fibrillation group; C-VF, continuous ventricular fibrillation group; I-VF,
intermittent ventricular fibrillation group.
There was either late or no contracture in groups 3 and 6. There was no contracture in groups 8 and 9, although LVEDP was elevated to around 40 mm Hg (see text). 
Values are mean ± SEM. Abbreviations are as in Table I.
*P < .05 versus group 1. 
†P < .05 versus groups 1, 2, and 5. 
‡P < .05 versus all groups. 
§P < .05 versus group 5.
degree of recovery was obtained in hearts subjected to
multidose cardioplegic infusion (every 10 minutes)
throughout 40 minutes of continuous global ischemia
(group 3); however, similar recovery was obtained in
hearts subjected to intermittent global ischemia with
VF (group 7). Interestingly, hearts from both these
groups recovered to a significantly higher level than
hearts protected with only a single infusion of cardio-
plegic solution and, as seen in Fig 2, the rate of recov-
ery was also significantly more rapid. When compared
Table I.  Baseline values (measured after 20 minutes of aerobic perfusion to achieve equilibration) of LVDP,
coronary flow, heart rate, and LVEDP
Groups
1: C-GI 2: S-CP 3: M-CP 4: C-GI+VF 
LVDP (mm Hg) 110.8 ± 4.1 109.7 ± 3.5 119.3 ± 5.6 107.8 ± 5.8 
Coronary flow (mL/min) 11.7 ± 0.7 10.6 ± 0.9 9.9 ± 0.7 9.5 ± 0.7
Heart rate (beats/min) 262.3 ± 9.6 274.2 ± 12.5 278.9 ± 8.9 290.8 ± 13.3 
LVEDP (mm Hg) 5.8 ± 0.6 5.2 ± 0.7 5.5 ± 0.6 4.2 ± 0.7
Values are mean ± SEM. There were no differences between any of these groups. LVDP, Left ventricular developed pressure; LVEDP, left ventricular end-diastolic 
pressure; C-GI, continuous global ischemia group; S-CP, single-dose cardioplegic infusion group; M-CP, multidose cardioplegic infusion group; C-GI+VF,
continuous global ischemia with ventricular fibrillation group; I-GI, intermittent global ischemia group; I-CP, intermittent cardioplegic infusion group; 
I-GI+VF, intermittent global ischemia with ventricular fibrillation group; C-VF, continuous ventricular fibrillation group; I-VF, intermittent ventricular 
fibrillation group.
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with hearts subjected to continuous (40 minutes) glob-
al ischemia (group 1; control), all but one group had a
significantly better degree of recovery; the exception
was group 4, hearts in which VF was imposed on glob-
al ischemia, which showed a tendency for a lower
degree of recovery (although this difference did not
reach significance). The significance of between-group
post hoc analysis for LVDP is shown in Table II.
Changes in LVEDP with time. Ischemic contrac-
ture (elevated LVEDP) occurred in all groups sub-
jected to global ischemia (groups 1-7); Table III
shows time to onset (minutes), time to peak (min-
utes), and peak (millimeters of mercury) of contrac-
ture. In hearts from groups 3 and 6, either no con-
tracture or late and incomplete contracture occurred;
consequently, contracture measurements were not
P value
Group 5 Group 6 Group 7 Group 8 Group 9
<.0001 <.0001 <.0001 .0009 .0005
.0074 .0271 .0004 .6719 .9188
.0934 .034 .4197 <.0001 <.0001
<.0001 <.0001 <.0001 <.0001 <.0001
— .6414 .3743 .005 .011
.6414 — .1783 .0171 .034
.3743 .1783 — .0004 .0009
.005 .0171 .0004 — .7689
.011 .034 .0009 .7689 —
Groups
5: I-GI 6: I-CP 7: I-GI+VF 8: C-VF 9: I-VF
18.6 ± 1.4 — 14.0 ± 1.1§ — —
36.2 ± 3.4 — 20.2 ± 1.9§ — —
66.0 ± 4.6 — 89.3 ± 5.3§ — —
Groups
5: I-GI 6: I-CP 7: I-GI+VF 8: C-VF 9: I-VF
111.8 ± 6.2 127.7 ± 3.3 111.8 ± 5.5 122.7 ± 4.7 111.5 ± 6.7
10.5 ± 0.7 10.4 ± 0.6 11.2 ± 1.4 11.8 ± 0.5 11.2 ± 0.7
269.1 ± 13.3 262.1 ± 14.4 284.2 ± 15.0 292.0 ± 13.7 283.1 ± 11.3
4.5 ± 0.3 5.3 ± 1.0 5.3 ± 0.5 4.3 ± 0.4 5.7 ± 0.6
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possible in these hearts. In addition, hearts subjected
to VF with maintained perfusion (groups 8 and 9) did
not exhibit contracture, although LVEDP was
increased to around 40 mm Hg (range 34-56 mm Hg)
as a result of the VF. As shown in Table III, similar
contracture measurements were obtained in hearts
subjected to global ischemia alone (either continuous
or intermittent), but the degree of recovery of LVDP
was significantly higher with intermittent ischemia
(Fig 3). Cardioplegic protection, however, prolonged
the ischemic duration before contracture occurred
and the extent was reduced, although the recovery of
LVDP was similar to that of intermittent ischemia. In
contrast, VF associated with either continuous or
intermittent global ischemia significantly shortened
the ischemic duration before the occurrence of con-
tracture and significantly increased the extent of con-
tracture. Although the contracture characteristics
with VF were very similar, the extent of recovery of
LVDP was different; recovery after continuous
ischemia and VF was poor whereas it was good after
intermittent ischemia and VF.
Changes in postischemic LVEDP with time during
reperfusion are shown in Fig 4. At the onset of reperfu-
sion, LVEDPs in all groups were relatively high (vary-
ing between 35.2 and 58.7 mm Hg); however, in groups
1, 2, and 4, LVEDP increased further to a peak at 5
minutes, subsequently reducing during the rest of the
reperfusion period but still remaining significantly ele-
vated. In all other groups, LVEDP was not different
from baseline values and there were no differences in
between-group values.
Discussion
The present study demonstrated that, with the same
cumulative duration of ischemia, intermittent cross-
clamping with VF provided a similar level of myocar-
dial protection as that achieved with multidose cardio-
plegic ischemic arrest. In addition, myocardial
protection by intermittent crossclamping with VF was
more effective than single-dose cardioplegic ischemic
arrest and either continuous or intermittent VF with
coronary perfusion.
In the 1970s, numerous experimental studies into the
myocardial protective effect of VF were undertaken.12-16
Studies from Buckberg’s group12,15 demonstrated that
electrically maintained VF caused subendocardial
ischemia, shown by acidosis, potassium loss, and a fall
in lactate extraction, all of which contributed to suben-
docardial injury and impaired post-VF function despite
apparently normal coronary perfusion. In further stud-
ies, Hottenrott and Buckberg13 presented evidence that
ventricular distention secondary to VF added to the
occurrence of subendocardial underperfusion. The sug-
gested mechanism by which flow was shunted away
from the subendocardium during VF was the compres-
sive force exerted on subendocardial vessels, either by
the strength of VF or from elevated intracavity pressure
caused by malfunction of the ventricular vent, leading
to the evolution of myocardial edema as ischemia was
prolonged.14 Moreover, Hearse, Stewart, and Chain16
demonstrated that, in hearts subjected to electrically
induced VF during coronary perfusion, the recovery of
cardiac function was reduced and myocardial adeno-
sine triphosphate and creatine phosphate levels were
considerably depleted, indicating increased myocardial
energy consumption.
In our study, intraventricular pressure (LVEDP)
increased in hearts subjected to VF with coronary perfu-
sion (groups 8 and 9) to approximately 40 mm Hg (range
34-56 mm Hg). In these hearts, coronary flow was main-
tained close to (or higher than) baseline values, which
suggests that adequate coronary perfusion was main-
tained. From our data, however, it was not possible to
determine whether underperfusion occurred in the
subendocardium13; it is possible that the maintained
coronary flow reflects an increased flow in the other
regions (coronary steal). This theory may be supported
by our observation that continuous or intermittent VF, in
combination with continuous perfusion during VF
(groups 8 and 9, respectively), produced a significant
reduction in recovery of function when compared with
either multidose cardioplegia or intermittent crossclamp-
ing with VF (groups 3 and 7, respectively).
The role of left ventricular distention on myocardial
injury has been evaluated in isolated cat hearts perfused
with crystalloid solution and subjected to cardioplegic
ischemic arrest or VF with maintained coronary perfu-
sion.17 Increased LVEDP (induced by inflating an intra-
ventricular balloon) during ischemia did not influence
myocardial gas tension, left ventricular function, coro-
nary blood flow, endocardial/epicardial blood flow ratio,
or myocardial water content. In contrast, fibrillating
hearts with maintained perfusion exhibited decreased
function, impaired subendocardial blood flow, and ele-
vated carbon dioxide tension, confirming previous
results12-15 of the detrimental effects of VF. Thus, left
ventricular distention does not appear to be detrimental
during periods of ischemia (no coronary flow), but dis-
tention with VF and maintained coronary perfusion is
harmful. Our data support this theory; hearts in groups 8
and 9, which were subjected to VF with maintained per-
fusion (in which LVEDP was around 40 mm Hg) recov-
ered to a significantly lesser degree than hearts subjected
to intermittent ischemia with VF (group 7), in which con-
tracture-generated LVEDPs rose to around 90 mm Hg. In
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addition, our results indicate that application of VF dur-
ing crossclamp ischemia (group 7), which is applied to
induce a still, nonbeating heart during surgery, does not
exacerbate any ischemic injury (group 5). These results
confirm the relative safety of using intermittent cross-
clamping with VF during coronary artery bypass surgery.
In this study, the lowest degree of recovery of LVDP
was observed in hearts in which VF was induced
throughout continuous (40 minutes) global ischemia
(group 4); in contrast, intermittent global ischemia
with the same total cumulative ischemic duration (40
minutes), either with or without induction of VF
(groups 7 and 5, respectively), recovered to a signifi-
cantly higher level. Similar results have previously
been shown by Engelman and colleagues18 in nonhy-
pertrophic pig hearts. When normothermic ischemic
arrest with VF was induced for 15 minutes, no mal-
distribution of coronary flow or loss of the hyperemic
response was observed, even if this protocol was
repeated 6 times with only 5 minutes of reperfusion
separating the ischemic intervals each time. In con-
trast, prolonging the duration of ischemia with VF to
30 minutes (again with only 5 minutes of reperfusion
between intervals) led to a maldistribution of flow
away from the endocardium, as well as the loss of the
hyperemic response. Thus, the addition of VF to
ischemia had no significant detrimental effect when
the ischemic durations were short (even up to 15 min-
utes) but, with prolonged ischemia and VF, severe
myocardial damage occurred.
Our results showed that intermittent global ischemia
(with or without VF) preserved postischemic recovery
of LVDP to a level similar to that of multidose cardio-
plegia. It is tempting to speculate that intermittent
ischemia may be protecting the myocardium in a man-
ner similar to that of ischemic preconditioning19; how-
ever, there are a number of differences between inter-
mittent ischemia and classic preconditioning. The
ischemic period is longer than those usually used to
induce a preconditioning protection, although some
studies20 have used similar durations (2 episodes of 8
minutes of ischemia and 8 minutes of reperfusion) and
obtained excellent preconditioning protection in pig
hearts. The most obvious difference is the absence of
the prolonged ischemic period after the precondition-
ing stimulus, but it is possible that the initial ischemia-
reperfusion episode protects the subsequent episodes.
In fact, this was the question addressed in a study of
cardiopulmonary bypass in dogs by Abd-Elfattah,
Ding, and Wechsler21; they used a protocol similar to
that of the present study, comparing 60 minutes of nor-
mothermic global ischemia to 6 episodes of 10 minutes
of normothermic global ischemia and 10 minutes of
reperfusion. Interestingly, adenosine triphosphate lev-
els were maintained after the second episode of
ischemia and reperfusion and were significantly higher
at the end of the intermittent protocol than after sus-
tained ischemia. In addition, purine release was limited
and cardiac function was significantly better than that
obtained with the sustained ischemia group. It was sug-
Fig 4. Changes in LVEDP during reperfusion (expressed as absolute value in millimeters of mercury). Values are
the mean of at least 6 hearts per group ± SEM. LVEDP, Left ventricular end-diastolic pressure; N.S., nonsignifi-
cant; C-GI, continuous global ischemia group; S-CP, single-dose cardioplegic infusion group; M-CP, multidose car-
dioplegic infusion group; C-GI+VF, continuous global ischemia with ventricular fibrillation group; I-GI, intermit-
tent global ischemia group; I-CP, intermittent cardioplegic infusion group; I-GI+VF, intermittent global ischemia
with ventricular fibrillation group; C-VF, continuous ventricular fibrillation group; I-VF, intermittent ventricular
fibrillation group.
gested that the intermittent ischemia and reperfusion
augmented the endogenous protective mechanism or
mechanisms of “preconditioning.” However, the pre-
sent study was not intended to examine whether inter-
mittent global ischemia (either with or without VF)
exerted any protective effect by a preconditioning
mechanism, although further studies appear warranted.
Marked differences exist between the present study,
the more recent clinical studies,5-11 and previous exper-
imental and clinical investigations,22-25 in which a loss
of cardiac protection was demonstrated when intermit-
tent crossclamping (global ischemia) was used. These
differences involve the relative durations of ischemia
and reperfusion that were used; when repeated
episodes of ischemia of around 10 to 20 minutes in
duration were interspersed with reperfusion durations
of only 3 to 5 minutes, poor cardiac protection was
observed. Thus, in these studies, the ischemic dura-
tion was 3 to 6 times longer than the reperfusion
interval. In contrast, in those studies in which a car-
dioprotective effect of intermittent crossclamping has
been demonstrated,5-11,26 a protocol was used in which
repeated episodes of 10 minutes of ischemia were fol-
lowed by 10 to 15 minutes of reperfusion; thus, the
reperfusion duration was at least as long as the preced-
ing duration. These results were similar to those
achieved in the present study, in which intermittent
ischemic durations of 10 minutes, followed by reperfu-
sion for 10 minutes, resulted in a high level of recovery
of function, regardless of whether VF was induced dur-
ing ischemia. It has previously been shown27 in the pig
heart that myocardial injury associated with intermit-
tent ischemia and reperfusion can be exacerbated by
coincident VF, by shortening the period of reperfusion,
extending the periods of ischemia, or by using high per-
fusion pressure. Of these factors, the most critical
determinant to sustain adequate subendocardial perfu-
sion was the duration of reperfusion. Benzing and
coworkers22 concluded that the longer the individual
ischemic intervals or the shorter the periods of reperfu-
sion, the greater is the likelihood of tissue injury. Thus,
the time ratio of ischemic duration to reperfusion dura-
tion appears to be the important factor in determining
how well the myocardium will recover. Ischemic pre-
conditioning is induced by a short period (2-5 minutes)
of ischemia followed by a period of reperfusion (5-10
minutes) before the sustained period of ischemia. A
growing body of evidence suggests that the duration
and number of cycles of ischemia and reperfusion nec-
essary to confer protection may vary between species
and between the end points assessed.28 In studies in
which the time ratio of ischemia to reperfusion is high
(such as was the case in previous studies22-25), any
potential benefit that might have occurred as a result of
ischemic preconditioning was not seen. In fact, this
high ratio, together with the longer total ischemic time,
caused severe myocardial injury.
In fairness to these earlier studies, the protocols of
ischemia and reperfusion used in basic experimental
studies were influenced by the clinical techniques of
myocardial protection at that time. In the 1970s, inter-
mittent crossclamping was used not only during coro-
nary artery bypass surgery but also during other types
of cardiac operations, such as valve replacement for
valve disease or intracardiac repair for congenital heart
disease. During cardiac operations, it is not possible to
continue the operation during reperfusion periods; con-
sequently, the duration of ischemia had to be much
longer than the duration of reperfusion. Coronary
artery bypass surgery, however, is the exception
because the proximal ends of grafts can be sutured dur-
ing reperfusion. Considering the circumstances men-
tioned above, we would suggest that intermittent
ischemia with VF is suitable for myocardial preserva-
tion during coronary artery surgery but is not a good
technique to protect the myocardium during other car-
diac operations.
Limitations of the study
We concede that the present findings were made in
the normal rat heart. Therefore, we could not evalu-
ate the effect of cardioplegic maldistribution and any
potential disadvantage (or advantage) of intermittent
crossclamping with VF in the diseased heart.14,21
Another possible limitation of the present study may
be the use of an isolated heart preparation that does
not possess a collateral circulation (a notable differ-
ence from the clinical situation). In these studies, VF
was maintained by continuous alternating current
stimulation. This was necessary because the rat heart
is too small (has insufficient mass of ventricular tis-
sue) for VF to be maintained from a short stimulus
(the “critical mass” theory). We appreciate that either
a short VF stimulus or spontaneous VF is sufficient
for VF to be maintained in the clinical setting and
that these differences may influence the outcome of
the results, since spontaneous VF has been shown to
be less damaging.12
Conclusion
Optimal myocardial protection was obtained both
with multidose crystalloid cardioplegia during continu-
ous global ischemia and with intermittent crossclamp-
ing (either with or without VF). This study demon-
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strates that intrinsic myocardial protection was
obtained with intermittent crossclamping with VF, and
therefore this technique should provide good myocar-
dial protection during coronary artery bypass surgery.
Further studies are warranted into the mechanism by
which this protection is achieved and into the optimal
ratio of ischemia to reperfusion duration.
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